Interventions. Copies: This document is available on the World Wide Web sites of the
American College of Cardiology (www. cardiosource. org), the American Heart Association …

There remains uncertainty over optimal antithrombotic management strategy for patients
with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing …

The article focuses on a study which compared the safety of two unfractionated heparin
regimens during percutaneous coronary intervention (PCI) in patients with non-ST-segment …

Percutaneous coronary intervention (PCI) is the most commonly performed invasive
therapeutic cardiac procedure and plays an important role in the treatment of ischemic heart …

Aims: Surgical endarterectomy is the therapy of choice for atherosclerotic common femoral
artery (CFA) obstruction. Recently, some large single-centre series have shown …

Percutaneous coronary intervention (PCI) induces thrombin generation and is associated
with the risk of acute, subacute, or long-term ischaemic events. Therefore, intravenous …

Aims Although a 140 U/kg dose of unfractionated heparin (UFH) was comparable with
bivalirudin in terms of net clinical outcome in the Intracoronary Stenting and Antithrombotic …

Background—The optimal degree of heparin anticoagulation for peripheral vascular
interventions (PVIs) has not been defined. We sought to correlate total heparin dose and …

Major bleeding complications after percutaneous coronary intervention (PCI) increase
patient morbidity, prolong the hospital stay and costs, and are associated with reduced …

The selection of antithrombotic strategies continue to be of utmost importance during
percutaneous coronary intervention (PCI) and have evolved over the past 40 years …